Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer.
about
Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer.The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib.Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats.The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers.Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study.Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug Label.
P2860
Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Population pharmacokinetics an ...... th non-small cell lung cancer.
@en
Population pharmacokinetics an ...... th non-small cell lung cancer.
@nl
type
label
Population pharmacokinetics an ...... th non-small cell lung cancer.
@en
Population pharmacokinetics an ...... th non-small cell lung cancer.
@nl
prefLabel
Population pharmacokinetics an ...... th non-small cell lung cancer.
@en
Population pharmacokinetics an ...... th non-small cell lung cancer.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetics an ...... th non-small cell lung cancer.
@en
P2093
Craig Comisar
Eugène Cox
Han Witjes
John Maringwa
Karthick Vishwanathan
Kathryn Brown
Mireille Cantarini
Rik de Greef
P2860
P304
P356
10.1111/BCP.13223
P407
P577
2017-02-06T00:00:00Z